OPRL1 anticorps
Aperçu rapide pour OPRL1 anticorps (ABIN7117119)
Antigène
Voir toutes OPRL1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Fonction
- OPRL1 antibody
-
Purification
- Immunogen affinity purified
-
Pureté
- ≥95 % as determined by SDS-PAGE
-
Immunogène
-
Immunogen sequence: peptide, Cytoplasmic domain
Immunogen: opiate receptor-like 1
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB: 1:500-1:2000, IP: 1:200-1:1000, IHC: 1:20-1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freeze / thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C for 12 months
-
Date de péremption
- 12 months
-
-
- OPRL1 (Opiate Receptor-Like 1 (OPRL1))
-
Autre désignation
- OPRL1
-
Sujet
-
Synonyms: Nociceptin receptor|Kappa-type 3 opioid receptor (KOR-3)|Orphanin FQ receptor|OPRL1|OOR|ORL1
Background: G-protein coupled opioid receptor that functions as receptor for the endogenous neuropeptide nociceptin. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins(G proteins) and modulates the activity of down-stream effectors. Signaling via G proteins mediates inhibition of adenylate cyclase activity and calcium channel activity. Arrestins modulate signaling via G proteins and mediate the activation of alternative signaling pathways that lead to the activation of MAP kinases. Plays a role in modulating nociception and the perception of pain. Plays a role in the regulation of locomotor activity by the neuropeptide nociceptin.
-
Poids moléculaire
- 45 kDa
-
ID gène
- 4987
-
UniProt
- P41146
Antigène
-